These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Considerations in the Diagnosis and Management of Pulmonary Hypertension Associated With Left Heart Disease. Ilonze OJ; Ebong IA; Guglin M; Nair A; Rich J; McLaughlin V; Tedford RJ; Mazimba S JACC Heart Fail; 2024 Aug; 12(8):1328-1342. PubMed ID: 38970588 [TBL] [Abstract][Full Text] [Related]
11. Update in approaches to pulmonary hypertension because of left heart disease. Kennedy JLW; Mihalek AD Curr Opin Pulm Med; 2022 Sep; 28(5):337-342. PubMed ID: 35838362 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary Hypertension Due to Left Heart Disease-A Practical Approach to Diagnosis and Management. Lee F; Mielniczuk LM Can J Cardiol; 2021 Apr; 37(4):572-584. PubMed ID: 33217522 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy. Al-Omary MS; Sugito S; Boyle AJ; Sverdlov AL; Collins NJ Hypertension; 2020 Jun; 75(6):1397-1408. PubMed ID: 32336230 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes. Palazzini M; Dardi F; Manes A; Bacchi Reggiani ML; Gotti E; Rinaldi A; Albini A; Monti E; Galiè N Eur J Heart Fail; 2018 Feb; 20(2):248-255. PubMed ID: 28464427 [TBL] [Abstract][Full Text] [Related]
15. [2022 ESC/ERS guidelines on the diagnostics and treatment of pulmonary hypertension : A focussed review]. Rosenkranz S Herz; 2023 Feb; 48(1):23-30. PubMed ID: 36648489 [TBL] [Abstract][Full Text] [Related]
16. Corrected MRI Pulmonary Transit Time for Identification of Combined Precapillary and Postcapillary Pulmonary Hypertension in Patients With Left Heart Disease. Gong C; Guo X; Wan K; Chen C; Chen X; Guo J; He J; Yin L; Wen B; Pu S; Chen Y J Magn Reson Imaging; 2023 May; 57(5):1518-1528. PubMed ID: 37021578 [TBL] [Abstract][Full Text] [Related]
17. Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease. Huston JH; Shah SJ Circ Res; 2022 Apr; 130(9):1382-1403. PubMed ID: 35482841 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension associated with left heart disease: Updated Recommendations of the Cologne Consensus Conference 2018. Rosenkranz S; Lang IM; Blindt R; Bonderman D; Bruch L; Diller GP; Felgendreher R; Gerges C; Hohenforst-Schmidt W; Holt S; Jung C; Kindermann I; Kramer T; Kübler WM; Mitrovic V; Riedel A; Rieth A; Schmeisser A; Wachter R; Weil J; Opitz CF Int J Cardiol; 2018 Dec; 272S():53-62. PubMed ID: 30527996 [TBL] [Abstract][Full Text] [Related]
19. Impact of the new definition of pulmonary hypertension according to world symposium of pulmonary hypertension 2018 on diagnosis of post-capillary pulmonary hypertension. Pfeuffer-Jovic E; Weiner S; Wilkens H; Schmitt D; Frantz S; Held M Int J Cardiol; 2021 Jul; 335():105-110. PubMed ID: 33823213 [TBL] [Abstract][Full Text] [Related]
20. Pulmonary Hypertension in Left Heart Diseases: Pathophysiology, Hemodynamic Assessment and Therapeutic Management. Ltaief Z; Yerly P; Liaudet L Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]